Pathogenesis of cardiovascular alterations in dogs treated with minoxidil.
about
Evaluation of von Willebrand factor and von Willebrand factor propeptide in models of vascular endothelial cell activation, perturbation, and/or injurySuccessful drug development despite adverse preclinical findings part 2: examples.Endothelin receptor subtype distribution predisposes coronary arteries to damage.Biomarkers and mechanisms of drug-induced vascular injury in non-rodents.Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part I. Biotherapeutics.Nonclinical safety biomarkers of drug-induced vascular injury: current status and blueprint for the future.Pathologic features of naturally occurring juvenile polyarteritis in beagle dogs.Tissue-engineered blood vessels as promising tools for testing drug toxicity.Evidence for the nitric oxide pathway as a potential mode of action in fenoldopam-induced vascular injury.The toxicity of SCH 351591, a novel phosphodiesterase-4 inhibitor, in Cynomolgus monkeys.Coronary and systemic arterial physiology and immunohistochemical markers related to early coronary arterial lesions in beagle dogs given the potassium channel opener, ZD6169, or the endothelin receptor antagonist, ZD1611.Mesenteric arteriopathy in the rat induced by phosphodiesterase III inhibitors: an investigation of morphological, ultrastructural, and hemodynamic changes.Incidental histopathological findings in hearts of control beagle dogs in toxicity studies.Studies on coronary arteriopathy in dogs following administration of CI-1020, an endothelin A receptor antagonist.Coronary arteriopathy in monkeys following administration of CI-1020, an endothelin A receptor antagonist.Translation strategy for the qualification of drug-induced vascular injury biomarkers.Myocardial and reproductive system toxicity of SCH 351591, a selective phosphodiesterase-4 inhibitor, in CD-1 mice.
P2860
Q34466077-89DDC692-95E5-498C-9BBB-22A500810EBCQ35603965-D0A90839-22D3-4EC8-97FE-C18B29D56CEEQ35746003-7C6C55CA-9E0A-4E8C-84D4-A2F935523892Q36409440-FB32B9F6-0A12-4A81-9265-924E94C791C4Q38365744-D98CACF1-759C-4305-BF36-C311479753D7Q39201920-896C91F8-C360-4F63-A196-E20539745744Q40683475-F087B55B-7C66-478C-9072-D586A7C4CD4FQ41844621-250DA83D-11BF-4863-A605-81354A22B643Q44152031-37F3ABC2-2CE4-4EB4-8750-F0FE4D73ADE9Q44760134-FEFDB2CB-698B-4B15-89B1-56DE5F909484Q45169346-682CAA90-78EC-4F28-9574-0030C6CD5765Q46288153-44009334-70AB-4C0F-94DD-66944D8E94B2Q46715171-3723E234-A392-47F9-91E5-2FE204887D86Q50504733-AF32707F-628B-451B-8301-D9B58648C0B3Q50519292-E2DEF829-E0AB-4F99-ABE3-6847E44A7984Q51739310-B5F369C9-CF8C-4C3C-B8F5-0B15718DEAFAQ51908602-5AD6F1BB-4D8B-4159-846F-76287F438EE6
P2860
Pathogenesis of cardiovascular alterations in dogs treated with minoxidil.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Pathogenesis of cardiovascular alterations in dogs treated with minoxidil.
@en
Pathogenesis of cardiovascular alterations in dogs treated with minoxidil.
@nl
type
label
Pathogenesis of cardiovascular alterations in dogs treated with minoxidil.
@en
Pathogenesis of cardiovascular alterations in dogs treated with minoxidil.
@nl
prefLabel
Pathogenesis of cardiovascular alterations in dogs treated with minoxidil.
@en
Pathogenesis of cardiovascular alterations in dogs treated with minoxidil.
@nl
P2093
P1476
Pathogenesis of cardiovascular alterations in dogs treated with minoxidil.
@en
P2093
D W DuCharme
G M Mesfin
R G Carlson
S J Humphrey
P304
P356
10.1177/019262338901700113
P407
P433
P577
1989-01-01T00:00:00Z